Last €46.07 EUR
Change Today -1.42 / -3.00%
Volume 0.0
DG3 On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:06 AM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

celanese corp-series a (DG3) Snapshot

Open
€47.25
Previous Close
€47.49
Day High
€47.57
Day Low
€46.05
52 Week High
12/5/14 - €51.31
52 Week Low
02/4/14 - €36.08
Market Cap
7.1B
Average Volume 10 Days
19.7
EPS TTM
--
Shares Outstanding
153.6M
EX-Date
10/30/14
P/E TM
--
Dividend
€0.90
Dividend Yield
1.46%
Current Stock Chart for CELANESE CORP-SERIES A (DG3)

celanese corp-series a (DG3) Related Businessweek News

No Related Businessweek News Found

celanese corp-series a (DG3) Details

Celanese Corporation, a technology and specialty materials company, manufactures and sells value-added chemicals, thermoplastic polymers, and other chemical-based products worldwide. The company’s Advanced Engineered Materials segment develops, produces, and supplies specialty polymers for use in automotive, medical, and electronics products, as well as other consumer and industrial applications. Its Consumer Specialties segment provides cellulose acetate flakes, films, and tows for use in filter products applications; Sunett, a sweetener for use in various beverages, confections, and dairy products; Qorus, a sweetener system designed for low-to no-calorie carbonated and non-carbonated beverages, flavored waters, energy drinks, and milk and dairy products; and food protection ingredients, such as potassium sorbate and sorbic acids for use in foods, beverages, and personal care products. The company’s Industrial Specialties segment produces emulsions and ethylene vinyl acetate (EVA) performance polymers. This segment offers vinyl acetate-based emulsions for use in paints and coatings, adhesives, construction, glass fiber, textiles, and paper applications; EVA resins and compounds for use in flexible packaging films, lamination film products, hot melt adhesives, medical products, automotive, carpeting, and photovoltaic cells applications. Its Acetyl Intermediates segment offers acetyl products, including acetic acids, vinyl acetate monomers, acetic anhydride, and acetate esters for use as starting materials for colorants, paints, adhesives, coatings, and pharmaceuticals. The company also provides organic solvents and intermediates for pharmaceutical, agricultural, and chemical products. It has a strategic alliance with Airborne Oil & Gas to develop and supply composite materials for deepwater oil and gas pipelines. The company was founded in 1918 and is headquartered in Irving, Texas.

7,500 Employees
Last Reported Date: 01/22/15
Founded in 1918

celanese corp-series a (DG3) Top Compensated Officers

Chairman of the Board, Chief Executive Office...
Total Annual Compensation: $1.0M
Senior Vice President and General Counsel
Total Annual Compensation: $501.1K
Senior Vice President of Human Resources
Total Annual Compensation: $430.0K
Compensation as of Fiscal Year 2013.

celanese corp-series a (DG3) Key Developments

Celanese Corporation to Build New VAE Plant

Celanese Corporation announced that it still moving ahead with expansion in Asia, build a new VAE plant.

Celanese Corporation Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 2014; Provides Earnings Guidance for the Year 2015

Celanese Corporation reported unaudited consolidated earnings results for the fourth quarter and full year ended December 2014. For the fourth quarter, the company reported net sales of $1,559 million compared to $1,616 million a year ago. Operating loss was $54 million compared to operating profit of $944 million a year ago. Loss from continuing operations before tax was $31 million compared to earnings from continuing operations before tax of $955 million a year ago. Loss from continuing operations was $83 million or $0.54 per diluted share compared to earnings from continuing operations of $656 million or $4.17 per diluted share a year ago. Net loss attributable to the company was $84 million or $0.55 per diluted share compared to net earnings from attributable to the company of $654 million or $4.15 per diluted share a year ago. Net loss attributable to the company from continuing operations was $82 million or $0.54 per diluted share compared to net earnings from attributable to the company from continuing operations of $656 million or $4.16 per diluted share a year ago. Adjusted EPS increased to $1.28 from $1.04 in the prior year quarter. During the fourth quarter, the company generated operating cash flow of $166 million driven by continued strong earnings. Adjusted free cash flow for the quarter was $29 million. Operating EBITDA was $354 million compared to $428 million for the previous quarter. For the full year, the company reported net sales of $6,802 million compared to $6,510 million a year ago. Operating profit was $758 million compared to operating profit of $1,508 million a year ago. Earnings from continuing operations before tax was $941 million compared to earnings from continuing operations before tax of $1,609 million a year ago. Earnings from continuing operations were $627 million compared to earnings from continuing operations of $1,101 million a year ago. Net earnings attributable to the company were $624 million or $4.00 per diluted share compared to net earnings from attributable to the company of $1,101 million or $6.91 per diluted share a year ago. Net earnings attributable to the company from continuing operations was $631 million or $4.04 per diluted share compared to net earnings from attributable to the company from continuing operations of $1,101 million or $6.91 per diluted share a year ago. As of December 31, 2014, the company's net debt was below $2.0 billion, $114 million lower than prior year end. Adjusted EPS was $5.67 compared to $4.50 in the prior year quarter. Operating EBITDA was $1,558 million compared to $1,358 million a year ago. The company provided earnings guidance for the year 2015. The company anticipates adjusted EPS in 2015 to be in the range of $5.00 to $5.50 per share.

Celanese Corporation to Report Q4, 2014 Results on Jan 22, 2015

Celanese Corporation announced that they will report Q4, 2014 results at 5:00 PM, Eastern Standard Time on Jan 22, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DG3:GR €46.07 EUR -1.42

DG3 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arkema SA €63.60 EUR +1.02
Clariant AG SFr.14.93 CHF +0.21
FMC Corp $57.08 USD -0.02
Wacker Chemie AG €94.94 EUR +2.59
Westlake Chemical Corp $56.56 USD +0.26
View Industry Companies
 

Industry Analysis

DG3

Industry Average

Valuation DG3 Industry Range
Price/Earnings 13.2x
Price/Sales 1.2x
Price/Book 2.9x
Price/Cash Flow 12.8x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELANESE CORP-SERIES A, please visit www.celanese.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.